Bio Saga Blog - A Chronicle of Life Sciences & Informatics

Live Labcast: Enhance productivity with ease of use. Get the Most Out of Your Chromatography Data System with Agilent OpenLab CDSJoin us for live labcast on 30th March, 2020 from 3-4pm https://www.linkedin.com/posts/kameshwaran_labcast-session-get-the-most-out-of-your-activity-6648872465445552128-59f-

Data Integrity is your issue? How can I get tips on handling compliance queries during audits? Why data review process is so important ? Need answers to these questions? Join us for a live Labcast on Enhanced compliance, data integrity and tips on how to face audits on 23rd March from 3PM to 4PM IST https://lnkd.in/ffFZPTj https://www.linkedin.com/posts/kameshwaran_openlab-cds-enhanced-compliance-data-integrity-activity-6646664205363712000-a_LL

• Expands specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing • Complements leading life sciences offering with innovative sample preparation, assay and bioinformatics technologies  • Creates significant value and is expected to be immediately accretive to adjusted earnings per share after close WALTHAM, Mass. and VENLO, The Netherlands – March 3, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to the closing price of QIAGEN’s common stock on the Frankfurt Prime Standard on Ma...

Modules ▪ Bioinformatics ▪ Chemoinformatics ▪ Computer Aided Drug Discovery ▪ Molecular Modeling and Dynamics ▪ NGS Data Analysis ▪ Python and Bio-Python ▪ Perl and Bio-Perl Features ▪ Two Months Hands-on-training ▪ Four Months Extensive Project ▪ Research Paper Publication ▪ Review Paper Publication ▪ 6-Months Experience letter ▪ 100% Job Assistance ▪ 4 Interview calls ▪ HR sessions ▪ CV Making Apply today

IIIT-Delhi invites applications for admission in Ph.D. - Computational Biology (CB) program. We request you to share the information with potential candidates. Open Positions in below Research Areas: Decoding Cancer Hacking Mechanisms Computational Biochemistry, Mathematical, and systems biology modeling of metabolic networks of cancer systems Computational protein engineering Computational Biology, Network Biology, Systems Biology of Cancer and other Complex Diseases, Computational Gastronomy, Artificial Intelligence, Biomedical Data Informatics, Complex Networks, Natural Language Processing, Machine Learning, Data Analytics, and Mining For more information about our eligibility criteria, admission, selection process, please refer to our website:   https://www.iiitd.ac.in/ admission/phd/nov2019 Center for Computational Biology @IIITD  focuses on educational research at the interface of biological and computational scienc...

Recently I had shared a piece of news on the same topic:-  https://www.linkedin.com/feed/update/urn:li:activity:6590633791084163072/ # lims hashtag # laboratories hashtag # datamanagement hashtag # flexible Data Management Challenges In Next Generation Sequencing Since the beginning of the Human Genome Project, data management has been perceived as a key challenge for current molecular biology research. Before the finish of the nineties, advances had been set up that adequately bolstered most continuous activities, ordinarily based upon relational database management frameworks. Ongoing years have seen a sensational increment in the amount of information created by running projects that extends in this area. While it took over ten years, roughly three billion USD, and in excess of 200 gatherings worldwide to collect the main human genome, the present sequencing machines create a similar amount of crude information in seven days, at an expense of around 2000 USD...

"Prime editing" is more precise and more efficient than CRISPR and could herald a new era of genetic manipulation. The ability to edit the genes of human beings by changing the code of life -- DNA -- has dramatically improved over the last decade. Current tools, like  CRISPR-Cas9 and  base editors , are extremely powerful but have traditionally suffered from a lack of precision, high error rate and limited scope, hampering their ability to treat human genetic disease. A breakthrough gene-editing tool, developed by a team of researchers at Harvard University and unveiled Monday, has the ability to make extremely precise DNA edits, ushering in a new era of genetic manipulation. "In many respects this first report is the beginning rather than the end of a longstanding aspiration ... to be able to make any DNA change in any position of a living cell or organism including, potentially, human patients with genetic diseases," says David Liu, a chemist at Harvard'...